NASDAQ:ENTA

Enanta Pharmaceuticals News Headlines

$49.41
+0.93 (+1.92 %)
(As of 04/13/2021 04:30 PM ET)
Add
Compare
Today's Range
$48.13
Now: $49.41▼
$49.54
50-Day Range
$47.82
MA: $50.59▼
$53.16
52-Week Range
$40.32
Now: $49.41▼
$58.59
Volume83,449 shs
Average Volume152,354 shs
Market Capitalization$996.70 million
P/E RatioN/A
Dividend YieldN/A
Beta0.54

Headlines

Enanta Pharmaceuticals (NASDAQ ENTA) News Headlines Today

SourceHeadline
Zacks: Analysts Expect Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Will Post Quarterly Sales of $25.63 MillionZacks: Analysts Expect Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Will Post Quarterly Sales of $25.63 Million
americanbankingnews.com - April 9 at 3:06 AM
-$0.93 Earnings Per Share Expected for Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) This Quarter-$0.93 Earnings Per Share Expected for Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) This Quarter
americanbankingnews.com - April 7 at 2:18 PM
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Recommendation of "Hold" from BrokeragesEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Recommendation of "Hold" from Brokerages
americanbankingnews.com - March 22 at 8:48 AM
Enanta Pharmaceuticals to Present at SVB Leerink 10th Annual Global Healthcare ConferenceEnanta Pharmaceuticals to Present at SVB Leerink 10th Annual Global Healthcare Conference
finance.yahoo.com - February 18 at 7:30 PM
Enanta Pharmaceuticals Inc (ENTA) Q1 2021 Earnings Call TranscriptEnanta Pharmaceuticals Inc (ENTA) Q1 2021 Earnings Call Transcript
finance.yahoo.com - February 16 at 9:18 AM
This Just In: Analysts Are Boosting Their Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Outlook for This YearThis Just In: Analysts Are Boosting Their Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Outlook for This Year
nasdaq.com - February 14 at 2:15 PM
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2020 with Webcast and Conference Call Today at 4:30 p.m. ETEnanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET
finance.yahoo.com - February 8 at 7:51 PM
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue EstimatesEnanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - February 8 at 7:51 PM
Enanta Pharmaceuticals to Host Conference Call on February 8 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2020Enanta Pharmaceuticals to Host Conference Call on February 8 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2020
finance.yahoo.com - February 1 at 4:30 PM
Enanta Pharma is up after J.P. Morgan upgradeEnanta Pharma is up after J.P. Morgan upgrade
seekingalpha.com - January 31 at 7:36 AM
Enanta Pharmaceuticals Announces the Appointment of Brendan Luu as Senior Vice President, Business DevelopmentEnanta Pharmaceuticals Announces the Appointment of Brendan Luu as Senior Vice President, Business Development
finance.yahoo.com - January 26 at 11:17 AM
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and Outlook for 2021 at the 39th Annual J.P. Morgan Healthcare ConferenceEnanta Pharmaceuticals to Provide Updates on its Research and Development Programs and Outlook for 2021 at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 8 at 10:09 AM
Enanta Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare ConferenceEnanta Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 5 at 8:13 AM
Enanta Pharmaceuticals Announces the Appointment of John P. DeVincenzo, M.D. as Vice President of Translational VirologyEnanta Pharmaceuticals Announces the Appointment of John P. DeVincenzo, M.D. as Vice President of Translational Virology
finance.yahoo.com - January 5 at 8:13 AM
Is ENTA A Good Stock To Buy Now According To Hedge Funds?Is ENTA A Good Stock To Buy Now According To Hedge Funds?
finance.yahoo.com - December 19 at 11:25 PM
Enanta Pharmaceuticals Announces the Appointment of Tara L. Kieffer, Ph.D. as Senior Vice President, New Product Strategy and DevelopmentEnanta Pharmaceuticals Announces the Appointment of Tara L. Kieffer, Ph.D. as Senior Vice President, New Product Strategy and Development
finance.yahoo.com - December 8 at 7:37 AM
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Just Reported Earnings, And Analysts Cut Their Target PriceEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Just Reported Earnings, And Analysts Cut Their Target Price
finance.yahoo.com - November 25 at 7:51 AM
Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Misses Revenue EstimatesEnanta Pharmaceuticals (ENTA) Reports Q4 Loss, Misses Revenue Estimates
nasdaq.com - November 24 at 4:49 AM
Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q4 2020 Results - Earnings Call TranscriptEnanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - November 23 at 11:49 PM
Enanta Pharma EPS misses by $0.52, misses on revenueEnanta Pharma EPS misses by $0.52, misses on revenue
seekingalpha.com - November 23 at 6:49 PM
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2020Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2020
finance.yahoo.com - November 23 at 6:49 PM
Enanta Pharma Q4 2020 Earnings PreviewEnanta Pharma Q4 2020 Earnings Preview
seekingalpha.com - November 22 at 6:09 PM
Earnings Preview: Enanta PharmaceuticalsEarnings Preview: Enanta Pharmaceuticals
finance.yahoo.com - November 20 at 2:57 PM
Enanta Pharmaceuticals to Present at Upcoming Investor ConferencesEnanta Pharmaceuticals to Present at Upcoming Investor Conferences
finance.yahoo.com - November 18 at 9:23 AM
Enanta Pharmaceuticals to Host Conference Call on November 23 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2020Enanta Pharmaceuticals to Host Conference Call on November 23 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2020
finance.yahoo.com - November 16 at 7:47 AM
New Strong Sell Stocks for October 27thNew Strong Sell Stocks for October 27th
finance.yahoo.com - October 27 at 1:41 PM
Enanta initiates early-stage NASH study with EDP-297Enanta initiates early-stage NASH study with EDP-297
seekingalpha.com - September 14 at 1:07 PM
Enanta Pharmaceuticals Initiates Phase 1 Clinical Study of EDP-297, its Highly Potent and Targeted Follow-On Farnesoid X Receptor Agonist for the Treatment of Non-Alcoholic SteatohepatitisEnanta Pharmaceuticals Initiates Phase 1 Clinical Study of EDP-297, its Highly Potent and Targeted Follow-On Farnesoid X Receptor Agonist for the Treatment of Non-Alcoholic Steatohepatitis
finance.yahoo.com - September 14 at 7:54 AM
Enanta Pharmaceuticals to Participate in Upcoming September ConferencesEnanta Pharmaceuticals to Participate in Upcoming September Conferences
finance.yahoo.com - September 3 at 7:47 AM
Enanta Pharma reports encouraging data on HBV and NASH candidatesEnanta Pharma reports encouraging data on HBV and NASH candidates
seekingalpha.com - August 28 at 8:57 AM
Enanta Pharmaceuticals Presents New Data from its Hepatitis B and Non-Alcoholic Steatohepatitis Programs at the Digital International Liver Congress™ 2020Enanta Pharmaceuticals Presents New Data from its Hepatitis B and Non-Alcoholic Steatohepatitis Programs at the Digital International Liver Congress™ 2020
finance.yahoo.com - August 28 at 8:57 AM
Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the Liver (EASL) DigitalEnanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the Liver (EASL) Digital
bloomberg.com - August 23 at 6:16 PM
Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the Liver (EASL) Digital International Liver Congress™ 2020Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the Liver (EASL) Digital International Liver Congress™ 2020
finance.yahoo.com - August 20 at 9:52 AM
ENTA Aug 2020 55.000 callENTA Aug 2020 55.000 call
ca.finance.yahoo.com - August 19 at 8:42 AM
ENTA Sep 2020 45.000 putENTA Sep 2020 45.000 put
ca.finance.yahoo.com - August 19 at 8:42 AM
Enanta Pharmaceuticals Inc - ProfileEnanta Pharmaceuticals Inc - Profile
markets.businessinsider.com - August 19 at 8:42 AM
Were Hedge Funds Right About Ditching Enanta Pharmaceuticals Inc (ENTA)?Were Hedge Funds Right About Ditching Enanta Pharmaceuticals Inc (ENTA)?
finance.yahoo.com - August 7 at 9:58 AM
Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q3 2020 Results - Earnings Call TranscriptEnanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - August 5 at 7:48 AM
Enanta Pharmaceuticals Inc (ENTA) Q3 2020 Earnings Call TranscriptEnanta Pharmaceuticals Inc (ENTA) Q3 2020 Earnings Call Transcript
finance.yahoo.com - August 5 at 7:48 AM
Enanta Pharma EPS beats by $0.26, misses on revenueEnanta Pharma EPS beats by $0.26, misses on revenue
seekingalpha.com - August 4 at 7:58 PM
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2020 with Webcast and Conference Call Today at 4:30 p.m. ETEnanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET
finance.yahoo.com - August 4 at 7:58 PM
Recap: Enanta Pharmaceuticals Q3 EarningsRecap: Enanta Pharmaceuticals Q3 Earnings
finance.yahoo.com - August 4 at 7:58 PM
Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Misses Revenue EstimatesEnanta Pharmaceuticals (ENTA) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - August 4 at 7:58 PM
Enanta Pharma Q3 2020 Earnings PreviewEnanta Pharma Q3 2020 Earnings Preview
seekingalpha.com - August 3 at 2:00 PM
Enanta Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference 2020Enanta Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference 2020
finance.yahoo.com - August 3 at 9:00 AM
Enanta Pharmaceuticals to Host Conference Call on August 4 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Third Quarter Ended June 30, 2020Enanta Pharmaceuticals to Host Conference Call on August 4 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Third Quarter Ended June 30, 2020
finance.yahoo.com - July 28 at 10:31 AM
Are Enanta Pharmaceuticals, Inc.s (NASDAQ:ENTA) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?Are Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
finance.yahoo.com - July 17 at 2:53 PM
Are Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?Are Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
finance.yahoo.com - July 17 at 2:53 PM
Enanta Pharmaceuticals advances EDP-514 program for hepatitis B virusEnanta Pharmaceuticals advances EDP-514 program for hepatitis B virus
seekingalpha.com - July 9 at 1:23 PM
Enanta Pharmaceuticals Announces Clinical Trial Progress for EDP-514, its Lead Core Inhibitor for Hepatitis B VirusEnanta Pharmaceuticals Announces Clinical Trial Progress for EDP-514, its Lead Core Inhibitor for Hepatitis B Virus
finance.yahoo.com - July 9 at 8:22 AM
This page was last updated on 4/13/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.